Franklin Genomic Advancements ETFFranklin Genomic Advancements ETFFranklin Genomic Advancements ETF

Franklin Genomic Advancements ETF

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪9.20 M‬USD
Fund flows (1Y)
‪−1.86 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
0.6%

Om Franklin Genomic Advancements ETF

Issuer
Franklin Resources, Inc.
Brand
Franklin
Expense ratio
0.50%
Inception date
25 feb. 2020
Index tracked
No Underlying Index
Management style
Aktiv

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Theme
Niche
Framsteg inom genomiken
Strategi
Aktiv
Weighting scheme
Äganderätt
Selection criteria
Proprietary

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 3 maj 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Kommersiella tjänster
Aktier98.74%
Hälsoteknik77.31%
Kommersiella tjänster11.76%
Tekniska tjänster3.40%
Hälsotjänster3.16%
Processindustrier2.80%
Finans0.31%
Bonds, Cash & Other1.26%
Likvida medel1.26%
Stock breakdown by region
92%4%3%
Nordamerika92.69%
Europa4.29%
Asien3.02%
Latinamerika0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows